Does PEGASPARGASE Cause Diffuse alveolar damage? 66 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 66 reports of Diffuse alveolar damage have been filed in association with PEGASPARGASE (ONCASPAR). This represents 0.6% of all adverse event reports for PEGASPARGASE.
66
Reports of Diffuse alveolar damage with PEGASPARGASE
0.6%
of all PEGASPARGASE reports
66
Deaths
0
Hospitalizations
How Dangerous Is Diffuse alveolar damage From PEGASPARGASE?
Of the 66 reports, 66 (100.0%) resulted in death.
Is Diffuse alveolar damage Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEGASPARGASE. However, 66 reports have been filed with the FAERS database.
What Other Side Effects Does PEGASPARGASE Cause?
Febrile neutropenia (1,589)
Pyrexia (706)
Febrile bone marrow aplasia (668)
Sepsis (548)
Vomiting (530)
Neutropenia (521)
Abdominal pain (469)
Hypertriglyceridaemia (399)
Hypotension (388)
Thrombocytopenia (382)
What Other Drugs Cause Diffuse alveolar damage?
METHYLPREDNISOLONE (135)
CYCLOPHOSPHAMIDE (125)
PREDNISONE (122)
METHOTREXATE (112)
DEXAMETHASONE (84)
VINCRISTINE (78)
CYTARABINE (76)
DAUNORUBICIN (75)
ETOPOSIDE (73)
LEUCOVORIN (73)
Which PEGASPARGASE Alternatives Have Lower Diffuse alveolar damage Risk?
PEGASPARGASE vs PEGASYS
PEGASPARGASE vs PEGCETACOPLAN
PEGASPARGASE vs PEGFILGRASTIM
PEGASPARGASE vs PEGFILGRASTIM-APGF
PEGASPARGASE vs PEGFILGRASTIM-BMEZ